Heron Therapeutics, Inc. ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the appointment of Mark Hensley as Chief Operating Officer. Mr. Hensley has more than ...

Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its ...

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

Finding a better way to treat cancer, tackling the nursing shortage or just providing a better way to order tests are ...

Uncertainty surrounding President Trump’s import tariffs have been “cataclysmic” for the U.S. biotech industry, but the dust ...

Ohio middle school students will step into the shoes of real-world NASA professionals for a day of career exploration and hands-on activities at NASA's Glenn Research Center in Cleveland. Nearly 200 ...

Conference/Scientific publicationPentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025 25.04.2025 / 15:39 CET/CESTThe issuer is solely responsible ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...

AI is creating job opportunities, but no one can agree on how to title or organize the new roles, leaving job seekers with a lot to navigate.

A copy of the presentation materials can be accessed on the “ Publication ” section of the Company’s website at www.bioatla.com once the presentations have concluded.

Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the Company will be presenting on multiple programs in the lung, eye, and skin at upcoming scientific conferences being held ...